Annual Operating Expenses
$21.49 M
-$12.70 M-37.15%
December 31, 2023
Summary
- As of February 8, 2025, COEP annual total operating expenses is $21.49 million, with the most recent change of -$12.70 million (-37.15%) on December 31, 2023.
- During the last 3 years, COEP annual operating expenses has risen by +$15.71 million (+271.83%).
- COEP annual operating expenses is now -37.15% below its all-time high of $34.20 million, reached on December 31, 2022.
Performance
COEP Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Operating Expenses
$2.14 M
-$686.30 K-24.27%
September 1, 2024
Summary
- As of February 8, 2025, COEP quarterly total operating expenses is $2.14 million, with the most recent change of -$686.30 thousand (-24.27%) on September 1, 2024.
- Over the past year, COEP quarterly operating expenses has dropped by -$1.22 million (-36.37%).
- COEP quarterly operating expenses is now -86.37% below its all-time high of $15.72 million, reached on March 1, 2022.
Performance
COEP Quarterly Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Operating Expenses Formula
Operating Expenses = Selling, General & Administrative (SG&A) Expenses + Research & Development (R&D) Expenses + Depreciation & Amortization + Other Operating Expenses
COEP Operating Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -37.1% | -36.4% |
| 3 y3 years | +271.8% | -78.0% |
| 5 y5 years | +271.8% | -78.0% |
COEP Operating Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -37.1% | +52.2% | -86.4% | at low |
| 5 y | 5-year | -37.1% | +271.8% | -86.4% | +23.1% |
| alltime | all time | -37.1% | +271.8% | -86.4% | +23.1% |
Coeptis Therapeutics Operating Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $2.14 M(-24.3%) |
| Jun 2024 | - | $2.83 M(-3.2%) |
| Mar 2024 | - | $2.92 M(-13.2%) |
| Dec 2023 | $21.49 M(-37.2%) | $3.37 M(-57.4%) |
| Sep 2023 | - | $7.90 M(+114.4%) |
| Jun 2023 | - | $3.69 M(-43.6%) |
| Mar 2023 | - | $6.54 M(+103.1%) |
| Dec 2022 | $34.20 M | $3.22 M(-41.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2022 | - | $5.51 M(-43.5%) |
| Jun 2022 | - | $9.75 M(-38.0%) |
| Mar 2022 | - | $15.72 M(+416.9%) |
| Dec 2021 | $14.12 M(+144.3%) | - |
| Dec 2021 | - | $3.04 M(-55.0%) |
| Sep 2021 | - | $6.76 M(+161.9%) |
| Jun 2021 | - | $2.58 M(+48.3%) |
| Mar 2021 | - | $1.74 M |
| Dec 2020 | $5.78 M | - |
FAQ
- What is Coeptis Therapeutics annual total operating expenses?
- What is the all time high annual operating expenses for Coeptis Therapeutics?
- What is Coeptis Therapeutics annual operating expenses year-on-year change?
- What is Coeptis Therapeutics quarterly total operating expenses?
- What is the all time high quarterly operating expenses for Coeptis Therapeutics?
- What is Coeptis Therapeutics quarterly operating expenses year-on-year change?
What is Coeptis Therapeutics annual total operating expenses?
The current annual operating expenses of COEP is $21.49 M
What is the all time high annual operating expenses for Coeptis Therapeutics?
Coeptis Therapeutics all-time high annual total operating expenses is $34.20 M
What is Coeptis Therapeutics annual operating expenses year-on-year change?
Over the past year, COEP annual total operating expenses has changed by -$12.70 M (-37.15%)
What is Coeptis Therapeutics quarterly total operating expenses?
The current quarterly operating expenses of COEP is $2.14 M
What is the all time high quarterly operating expenses for Coeptis Therapeutics?
Coeptis Therapeutics all-time high quarterly total operating expenses is $15.72 M
What is Coeptis Therapeutics quarterly operating expenses year-on-year change?
Over the past year, COEP quarterly total operating expenses has changed by -$1.22 M (-36.37%)